Provided by Tiger Trade Technology Pte. Ltd.

Natera

317.50
-8.7600-2.68%
Volume:101.63K
Turnover:32.46M
Market Cap:45.47B
PE:-231.26
High:325.65
Open:320.41
Low:316.00
Close:326.26
52wk High:343.18
52wk Low:157.43
Shares:143.22M
Float Shares:139.00M
Volume Ratio:1.22
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3729
EPS(LYR):-1.5269
ROE:-12.54%
ROA:-8.08%
PB:24.96
PE(LYR):-207.94

Loading ...

Natera raises FY26 revenue view to $2.85B-$2.91B, consensus $2.8B

TIPRANKS
·
Aug 07

Natera, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Stock Track | Natera Soars 16.47% in After-Hours Trading on Q2 Earnings Beat and Raised 2026 Revenue Guidance

Stock Track
·
Aug 07

Natera Q2 FY26 Net Loss Narrows 33.65% to $67 Million; Revenue Rises 37.7% to $752.8 Million

Reuters
·
Aug 07

Natera Q2 Revenue Rises Beats Estimates on Higher Overall Test Volumes, Raises 2026 Outlook

Reuters
·
Aug 07

Natera Q2 EPS $(0.47) Beats $(0.51) Estimate, Sales $752.750M Beat $660.687M Estimate

Benzinga Earnings
·
Aug 07

GUIDANCE: (NTRA) Natera Expects Full Year 2026 Revenue Range $2.85B - $2.91B, vs. FactSet Est of $2.80B

MT Newswires Live
·
Aug 07

Earnings Flash (NTRA) Natera Posts Q2 Loss $0.47, vs. FactSet Est of $0.49 Loss

MT Newswires Live
·
Aug 07

Movement Alert|Natera Rises 8.15% in After-Hours Trading, Positive Market Reaction Following Quarterly Earnings Release

Market Focus
·
Aug 07

Natera Q2 EPS USD -0.47

Reuters
·
Aug 07

Natera’s SCORE-NHL Study Builds Long-Term Value in Lymphoma Monitoring

TIPRANKS
·
Aug 07

Natera CFO Michael Burkes Brophy Disposes of 795 Common Shares Worth $215,449.79

Reuters
·
Aug 06

Natera Seeks Japan PMDA Approval for Signatera Test in Muscle-Invasive Bladder Cancer

Reuters
·
Aug 05

Movement Alert|Natera Rises 5.08% in Regular Trading, Strong Earnings Preview and Signatera Milestones Drive Momentum

Market Focus
·
Jul 31

Natera Schedules Second-quarter Results Conference Call

Reuters
·
Jul 30

Press Release: Natera to Report Its Second Quarter Results on August 6, 2026

Dow Jones
·
Jul 30

Natera CFO Michael Burkes Brophy Disposes of USD 1.29 Million in Common Shares

Reuters
·
Jul 30

Natera’s New ctDNA-Guided Immunotherapy Trial Could Redefine Cancer Treatment Cycles

TIPRANKS
·
Jul 25

Natera (NTRA) Gets a Buy from BTIG

TIPRANKS
·
Jul 23

Bernstein Sticks to Their Buy Rating for Natera (NTRA)

TIPRANKS
·
Jul 23